The STK11 gene helps control how cells grow, use energy, and stay organized. This gene plays an important role in keeping cell growth in check, so harmful variants can lead to Peutz-Jeghers syndrome, with dark spots on the lips or mouth, polyps in the stomach or intestines, and a higher chance of some cancers. In cancer care, changes in the STK11 gene are also studied because they can shape how some tumors behave, especially in lung cancer.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in LearnHub.
Overview
STK11Gene function
What if the gene works
The STK11 gene helps control how cells grow, divide, and use energy. It also supports normal cell structure and helps keep tissues organized.
Risk
What if the gene does not work
Pathogenic variants in the STK11 gene most often cause Peutz-Jeghers syndrome, with dark lip or mouth spots and digestive tract polyps. Different variants can have milder or more severe effects and may influence when features appear and cancer risk.
Treatment
What does that mean for your treatment
A pathogenic variant in the STK11 gene does not currently point to a specific targeted drug. In current guidelines, treatment relevance is mainly regular surveillance and removal of larger gastrointestinal polyps to lower the chance of bleeding, blockage, and bowel telescoping. Care also includes cancer screening, which can guide the timing of surgery or other treatment if needed.
Conditions associated with STK11
Gene function
What if the gene works
Your cells use the STK11 gene to balance energy, growth, and organization. It helps them respond when fuel is low and keep their internal layout in order. Understanding STK11 gene function helps you see how tissues stay steady during everyday wear and repair.
Inside your cells, the STK11 gene helps detect when energy is running low. It switches on signals that help the cell use fuel more carefully and keep basic tasks going.
This gene helps cells match growth to the energy and nutrients available. By slowing growth when resources are limited, it supports steadier day to day cell activity.
The STK11 gene helps cells keep a clear top, bottom, and outer edge, called polarity (organized cell shape and direction). This helps tissues such as the gut lining stay orderly and work as a coordinated layer.
Through its protein, the STK11 gene turns on helper proteins that coordinate metabolism, movement, and cell housekeeping. This allows one energy related signal to guide several routine cell jobs at once.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
STK11 gene variants often weaken or switch off the protein’s signaling activity, so cells lose some control over growth and organization. In Peutz-Jeghers syndrome, a more disruptive variant, such as a truncating or whole-gene loss variant, usually has a larger functional effect than some missense changes. These differences help explain how STK11 gene variants affect Peutz-Jeghers syndrome.
How variants are linked to conditions
Pathogenic variants in the STK11 gene cause Peutz-Jeghers syndrome, an inherited condition with multiple polyps in the digestive tract and a characteristic pattern of dark skin spots. People with Peutz-Jeghers syndrome due to an STK11 gene variant also have a higher lifetime risk of several cancers, especially pancreatic, stomach, small bowel, colon, breast, cervical, ovarian, and testicular cancers. Finding a pathogenic variant in the STK11 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful change in the STK11 gene, much of the risk is set by the gene itself, especially for Peutz-Jeghers syndrome and related cancers. Other factors may play a role, but there is not enough evidence to say they clearly change STK11-related risk. What helps most is regular monitoring to find polyps, bleeding, or cancer early.
Inheritance of STK11 variants
STK11-related conditions such as Peutz-Jeghers syndrome are usually inherited in an autosomal dominant pattern, which means a child needs one altered copy of the STK11 gene to inherit the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. Some people are the first in their family to have it because the variant arose new (de novo) in them rather than being passed down. This is the main answer to how STK11 variants are inherited in families.
What does my STK11 result mean for my family?
For STK11, the main family pattern is dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same gene change and could consider genetic counseling or testing. Each child of someone with a disease-causing STK11 change has a 1 in 2, or 50%, chance of inheriting it. Some STK11 changes happen for the first time in one person, so a parent does not always carry it.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the STK11 gene uses blood or saliva to look for variants that may explain a personal or family history of certain polyps or cancers. A lab reads the DNA code and checks for small changes and larger missing or extra pieces. This is how doctors find out about STK11 variants.
When should I consider getting a genetic test?
Consider STK11 genetic testing if you or a close relative has Peutz-Jeghers syndrome, repeated bowel polyps, or dark blue-brown spots on the lips, mouth, fingers, or toes. It can also help explain a strong family history of certain cancers, including pancreatic, stomach, bowel, breast, or gynecologic cancers.
A genetic result is only one part of your health story
A genetic result may give useful insight, yet how much it can reveal varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers added context rather than certainty and is best understood as part of the broader picture of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, these results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, so the same treatment can feel stronger, weaker, or last for a different amount of time. These inherited differences are common and can influence how well a medicine works or how likely side effects are. Medication response also depends on other factors, including age, liver and kidney function, and other medicines you take.
What is Pharmacogenetics?
Pharmacogenetics focuses on how genetic differences shape a person’s response to medication. By examining links between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes affect how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the STK11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about medicines, side effects, or treatment changes are best discussed with your doctor. In cancer care, STK11 changes are being studied because they may affect how some tumors respond to certain treatments, especially immunotherapy, but this is not a routine guide for most medicines.
History
STK11 came to medical attention through research on Peutz-Jeghers syndrome, a rare inherited condition marked by dark skin spots and growths in the digestive tract. In 1998, researchers identified the STK11 gene, also called LKB1, as the main gene linked to this syndrome, helping explain why it can run in families. First described in the scientific literature as part of early genetics, this discovery gave families a clearer answer after years of relying only on visible features and family history. From these first observations, research expanded steadily. Scientists then recognized that inherited variants in the STK11 gene could also be tied to higher cancer risk in people with Peutz-Jeghers syndrome. That work made STK11 an important part of hereditary cancer genetics.